Search
for
Sort by
Research 241–270 of 1000+
- Alopecia Areata
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Catecholaminergic neurons boost fibroblast osteogenic activity in keloid
- The Muscarinic Acetylcholine Receptor in Dermal Papilla Cells Regulates Hair Growth
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Sorafenib-induced Facial Acneiform Eruption
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Vitamin D and the skin: Focus on a complex relationship: A review
- Emerging Therapies for Acne Vulgaris
- Alopecia - the search for novel agents continues
- Delta Opioid Receptors Presynaptically Regulate Cutaneous Mechanosensory Neuron Input to the Spinal Cord Dorsal Horn
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Overexpression of the calcium sensing receptor accelerates epidermal differentiation and permeability barrier formation in vivo
- Evidence for 1,25-Dihydroxyvitamin D3-independent Transactivation by the Vitamin D Receptor
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- Targeting of Smoothened for therapeutic gain
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Medical Therapies
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Edar Signaling in the Control of Hair Follicle Development
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata